Michel Baudry
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2023First federal award
$1.2MFederal grants as PI4 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
4 awards · $1.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| May 16, 2024 | NIH | STTR Phase I Testing the effects of a selective calpain-2 inhibitor on spontaneous recurrent seizures in mouse models of epilepsy | $19K | NEURAEGIS INC |
| May 9, 2024 | NIH | STTR Phase I Testing the effects of a selective calpain-2 inhibitor on spontaneous recurrent seizures in mouse models of epilepsy | $198K | NEURAEGIS INC |
| Sep 1, 2023 | NIH | STTR Phase I Testing the effects of a selective calpain-2 inhibitor on spontaneous recurrent seizures in mouse models of epilepsy | $489K | NEURAEGIS INC with WESTERN UNIVERSITY OF HEALTH SCIENCES |
| Aug 24, 2023 | NIH | STTR Phase I Testing the effects of a selective calpain-2 inhibitor on spontaneous recurrent seizures in mouse models of epilepsy | $489K | NEURAEGIS INC |
Peer ranks
Federal funding#1,602
Awards as PI#566
Patents#273
Companies
- NEURAEGIS INCLinked by awards · Biotech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.